The online version of this article (doi:10.1186/1477-7819-10-100) contains supplementary material, which is available to authorized users.
The authors declare that the authors have no competing interests.
The purpose of the research is to study the histopathology and expression of survivin, estrogen and progesterone receptors (ER/PR) in the endometrium of patients with dysfunctional uterine bleeding (DUB) treated with radiofrequency endometrial ablation (REA).
A total of 98 DUB patients were enrolled in this case–control study. Among them, 66 underwent REA treatment and 32 optioned for hormone therapy as the control group. Immunohistochemical analysis for survivin, ER and PR expression was carried out on endometrial tissue samples collected before and 6 to 7 months after treatment for both groups.
Both hormone and REA treatment ameliorated menstrual bleeding of DUB patients, with the latter showing a significantly higher effective rate. Endometrial surface tissue was replaced by fibrosis tissue in the REA treatment group. REA treatment also significantly reduced the expression of survivin, ER, and PR. Endometrial surface tissues collected from the hormone-treated control group neither showed any apparent morphological alteration nor in the expression of those receptors.
REA treatment changed endometrial surface tissue type from gland rich to gland poor, and significantly decreased the expression of survivin, ER, and PR. This may be an important contributing mechanism for the long-term curative effect and prevention of DUB recurrence.
Authors’ original file for figure 112957_2012_1114_MOESM1_ESM.tiff
Amir E, Richard HS: Dysfunctional uterine bleeding. 2010, http://emedicine.medscape.com/article/795587-overview,
Apgar BS, Kaufman AH, George-Nwogu U, Kittendorf A: Treatment of menorrhagia. Am Fam Physician. 2007, 75: 1813-1819. PubMed
Hodgson DA, Feldberg IB, Sharp N, Cronin N, Evans M, Hirschowitz L: Microwave endometrial ablation: development, clinical trials and outcomes at three years. Br J Obstet Gynecol. 1999, 106: 684-694. 10.1111/j.1471-0528.1999.tb08368.x. CrossRef
Li D: The curative effect of RU486 for the treatment of dysfunctional uterine bleeding (in Chinese - English abstract available). Chin J Mod Drug Appl. 2009, 3: 104-105.
Xiu-min F: Clinical analysis of mifepristone treatment of 68 cases of perimenopausal dysfunctional uterine bleeding (in Chinese - English abstract available). Medical Information. 2010, 23: 905-906.
Dequesne JH, Gallinat A, Garza-Leal JG, Sutton CJ, van der Pas HF, Wamsteker K, Chandler JG: Thermoregulated radiofrequency endometrial ablation. Int J Fertil Womens Med. 1997, 42: 311-318. PubMed
El-Nashar SA, Hopkins MR, Creedon DJ, Cliby WA, Famuyide AO: Efficacy of bipolar radiofrequency endometrial ablation vs thermal balloon ablation for management of menorrhagia: A population-based cohort. J Minim Invasive Gynecol. 2009, 16: 692-699. 10.1016/j.jmig.2009.06.022. PubMedCentralCrossRefPubMed
Yin GP, Chen M, Shao X, Zhu TY, Wang YZ: Radiofrequency minimally invasive treatment of uterine benign diseases (in Chinese - English abstract available). Progress Obstetrics and Gynecology. 2003, 12: 200-203.
Higham JM, O’Brien PM, Shaw RW: Assessment of menstrual blood loss using a pictorial chart. BJOG. 1990, 97: 734-739. 10.1111/j.1471-0528.1990.tb16249.x. CrossRef
Kalogiannidis I, Bobos M, Papanikolaou A, Makedos A, Amplianitis I, Vergote I, Nenopoulou E, Makedos G: Immunohistochemical bcl-2 expression, p53 overexpression, PR and ER status in endometrial carcinoma and survival outcomes. Eur J Gynaecol Oncol. 2008, 29: 19-25. PubMed
- Decreased expression of survivin, estrogen and progesterone receptors in endometrial tissues after radiofrequency treatment of dysfunctional uterine bleeding
- BioMed Central
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II